XML 50 R39.htm IDEA: XBRL DOCUMENT

Benefit Plans (Tables)

9 Months Ended

Jul. 31, 2022

Benefit Plans

Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations and Comprehensive Loss

Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):


		Three months Ended July 31,						Nine months Ended July 31,
		2022			2021			2022			2021
Cost of revenues		$	175		$	133		$	512		$	449
Administrative and selling expense			1,598			706			4,126			2,941
Research and development expense			135			33			319			97
		$	1,908		$	872		$	4,957		$	3,487

Summary of RSA and RSU Activity

The following table summarizes our RSA and RSU activity for the nine months ended July 31, 2022:


Restricted Stock Awards and Units			Shares		Weighted-Average Fair Value
Outstanding as of October 31, 2021			2,543,541		$	5.08
Granted – performance units			169,026			11.70
Granted – time-vesting restricted stock units			652,597			9.20
Vested			(88,388)			3.54
Outstanding as of January 31, 2022			3,276,776		$	6.27
Granted – time-vesting restricted stock units			85,804			5.52
Vested			(25,464)			9.57
Forfeited			(21,559)			9.05
Outstanding as of April 30, 2022			3,315,557			6.21
Granted – time-vesting restricted stock units			273,407			5.36
Vested			(2,022)			15.06
Forfeited			(13,588)			9.20
Outstanding as of July 31, 2022			3,573,354		$	6.13